1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. 1983

G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1980, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1983, Acta anatomica,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1994, Zhonghua nei ke za zhi,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
September 1992, The Journal of steroid biochemistry and molecular biology,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
May 1984, Acta paediatrica Scandinavica,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1985, Mineral and electrolyte metabolism,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
October 1980, Kidney international,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
May 1980, The American journal of physiology,
G Coen, and M Taccone Gallucci, and E Bonucci, and P Ballanti, and A R Bianchi, and G Bianchini, and M C Matteucci, and S Mazzaferro, and S Picca, and F Taggi, and G A Cinotti, and C U Casciani
January 1980, Contributions to nephrology,
Copied contents to your clipboard!